Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Short term Debt (2021)

Whitehawk Therapeutics (WHWK) has disclosed Short term Debt for 1 consecutive years, with $258000.0 as the latest value for Q4 2021.

  • On a quarterly basis, Short term Debt changed N/A to $258000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $258000.0, a N/A change, with the full-year FY2021 number at $258000.0, changed N/A from a year prior.
  • Short term Debt was $258000.0 for Q4 2021 at Whitehawk Therapeutics, up from $22000.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $258000.0 in Q4 2021 to a low of $22000.0 in Q3 2021.